-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on Praxis Precision Medicine, Maintains $582 Price Target

Benzinga·09/24/2026 09:46:02
Needham analyst Ami Fadia reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $582 price target.